JNJ

J&J sews up 5 years of coronavirus vaccine supply in $480M-plus deal with Emergent
J&J sews up 5 years of coronavirus vaccine supply in $480M-plus deal with Emergent
Fierce Pharma
JNJ
CDMOs
Emergent BioSolutions
vaccines
COVID-19
drug manufacturing
Flag link:
J&J’s Ebola vaccine approved in EU
J&J’s Ebola vaccine approved in EU
Pharmaforum
Europe
JNJ
ebola virus
Janssen
vaccines
Bavarian Nordic
Flag link:
J&J scraps late-stage study testing Stelara for lupus
J&J scraps late-stage study testing Stelara for lupus
Reuters
JNJ
Janssen
lupus
Stelara
clinical trials
Flag link:
With Sanofi entering the multiple myeloma market, J&J flashes data on new rare disease
With Sanofi entering the multiple myeloma market, J&J flashes data on new rare disease
Endpoints
EHA
JNJ
clinical trials
Darzalex
AL amyloidosis
Flag link:
EHA: Johnson & Johnson's Darzalex branches out beyond myeloma with AL amyloidosis win
EHA: Johnson & Johnson's Darzalex branches out beyond myeloma with AL amyloidosis win
Fierce Pharma
light chain amyloidosis
JNJ
Darzalex
EHA
Flag link:
J&J brings forward start of COVID-19 vaccine trial to next month
J&J brings forward start of COVID-19 vaccine trial to next month
Pharmaforum
JNJ
vaccines
Janssen
COVID-19
Ad26.COV2-S
Flag link:
The coronavirus vaccine frontrunners have emerged. Here's where they stand
The coronavirus vaccine frontrunners have emerged. Here's where they stand
BioPharma Dive
COVID-19
vaccines
Moderna Therapeutics
Cansino Biologics
Pfizer
BioNTech
Novavax
Inovio
Oxford BioMedica
AstraZeneca
Merck
JNJ
Sanofi
GSK
Flag link:
Is Moderna Really the Leader in the COVID-19 Vaccine Race?
Is Moderna Really the Leader in the COVID-19 Vaccine Race?
Motley Fool
vaccines
COVID-19
Moderna Therapeutics
AstraZeneca
Pfizer
JNJ
BioNTech
Merck
Sanofi
GSK
Novavax
Inovio
Flag link:
Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to Support
Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to Support
Motley Fool
vaccines
Donald Trump
Operation Warp Speed
COVID-19
Moderna Therapeutics
JNJ
Merck
Pfizer
AstraZeneca
BioNTech
Flag link:
Will Johnson & Johnson Acquire Arrowhead Pharmaceuticals?
Will Johnson & Johnson Acquire Arrowhead Pharmaceuticals?
Motley Fool
JNJ
Arrowhead Pharmaceuticals
M&A
Flag link:
If You Invested $10,000 in Johnson & Johnson’s IPO, This Is How Much Money You'd Have Now
If You Invested $10,000 in Johnson & Johnson’s IPO, This Is How Much Money You'd Have Now
Motley Fool
JNJ
IPOs
Flag link:
J&J holds its own on sales per employee
J&J holds its own on sales per employee
EP Vantage
JNJ
revenue per employee
Flag link:
Litigation-weary J&J pulls Baby Powder talc in North America
Litigation-weary J&J pulls Baby Powder talc in North America
Pharmaforum
JNJ
lawsuits
Flag link:
Johnson & Johnson's Oncology Team Posts Promising Cancer Trial Results
Johnson & Johnson's Oncology Team Posts Promising Cancer Trial Results
Motley Fool
JNJ
Multiple Myeloma
bispecific antibodies
JNJ-5957
teclistamab
clinical trials
Flag link:
J&J, AbbVie, Roche and more sponsor cancer content for concerned patients amid COVID-19 pandemic
J&J, AbbVie, Roche and more sponsor cancer content for concerned patients amid COVID-19 pandemic
Fierce Pharma
cancer
JNJ
AbbVie
Roche
pharma advertising
oncology
Flag link:
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report
Fierce Pharma
Teva Pharmaceutical
price fixing
generics
COVID-19
Sandoz
JNJ
Novartis
Taro Pharmaceuticals
Flag link:
Janssen Presents First Data from Phase 1 Study of BCMAxCD3 Bispecific Teclistamab in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
Janssen Presents First Data from Phase 1 Study of BCMAxCD3 Bispecific Teclistamab in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
BioSpace
JNJ
Janssen
teclistamab
JNJ-7957
clinical trials
ASCO 2020
Multiple Myeloma
Flag link:
What's it like to work on J&J's coronavirus vaccine? For one scientist, it's social distancing in the lab, late nights at home
What's it like to work on J&J's coronavirus vaccine? For one scientist, it's social distancing in the lab, late nights at home
Fierce Pharma
JNJ
drug development
vaccines
R&D
COVID-19
Flag link:
Janssen promotes R&D exec into newfound data science role
Janssen promotes R&D exec into newfound data science role
Fierce Biotech
JNJ
Janssen
R&D
data science
Najat Khan
Flag link:
Here’s how some big U.S. drugmakers expect Covid-19 to affect them this year
Here’s how some big U.S. drugmakers expect Covid-19 to affect them this year
MedCity News
COVID-19
pandemic
Gilead Sciences
Pfizer
Eli Lilly
JNJ
Merck
Amgen
Flag link:

Pages